Clinical Trials in Seattle

Showing 1821-1840 of 8,049 trials

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

NCT05822609

The primary objective of this study is to determine the effects of semaglutide on kidney oxygenation and function in type 1 diabetes. The secondary objective is to determine the glycemic effects and safety of semaglutide in type 1 diabetes.

Diabetic Kidney DiseaseType 1 Diabetes

University of Washington60 participantsStarted Apr 2024

Aurora, Colorado, United States • Seattle, Washington, United States • Spokane, Washington, United States +1 more locations

RECRUITINGPhase 3< 1 mile

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

NCT04462770

This is a multicenter, Phase 3, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of clemizole hydrochloride (EPX-100) as adjunctive therapy in children and adult participants with Dravet syndrome (DS).

Dravet Syndrome

Epygenix150 participantsStarted Sep 2020

Los Angeles, California, United States • Orange, California, United States • San Francisco, California, United States +43 more locations

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

Find Trials by Condition in Seattle

Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma

Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)

Acalabrutinib, Obinutuzumab and Chlorambucil in Treatment naïve CLL

Clinical and Basic Investigations Into Congenital Disorders of Glycosylation

The Diabetes Prevention Program Outcomes Study AD/ADRD Project

Luveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age With Relapsed/Refractory CBFA2T3::GLIS2 AML

Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

Evaluation of Efficacy, Safety and Tolerability of VeraCept IUS

Study of Safety and Effectiveness of the Boston Orthokeratology Shaping Lens in the Arise Orthokeratology Lens

Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction

Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder

A Phase 3 Study of Pembrolizumab + Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma (Keynote-252 / ECHO-301)

A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression

Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2)

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

A Stepped-Wedge Cluster Randomized Trial of a Digital App to Support Medication-Assisted Treatment in Individuals With Opioid Use Disorder

A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer